CONDENSED STATEMENTS OF OPERATIONS - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|---|
Apr. 20, 2026 |
Dec. 31, 2025 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2026 |
|
| CONDENSED STATEMENTS OF OPERATIONS | |||||
| General and administrative expenses | $ 659 | $ 82,675 | $ 119,944 | ||
| Loss from operations | (659) | (82,675) | (119,944) | ||
| Other expense: | |||||
| PIPE subscription expense | $ (100,000,000) | (100,000,000) | (100,000,000) | ||
| Change in fair value of PIPE subscription derivative liability | (37,942,000) | (37,942,000) | |||
| Total other expense | (137,942,000) | (137,942,000) | |||
| Net Loss | $ (659) | $ (138,024,675) | $ (37,269) | $ (138,061,944) | |
| Weighted average shares of common stock outstanding, Basic (in shares) | 100 | 100 | 100 | ||
| Weighted average shares of common stock outstanding, Diluted (in shares) | 100 | 100 | 100 | ||
| Basic net loss per share of common stock (in dollars per share) | $ (6.59) | $ (1,380,246.75) | $ (1,380,619.44) | ||
| Diluted net loss per share of common stock (in dollars per share) | $ (6.59) | $ (1,380,246.75) | $ (1,380,619.44) | ||
| X | ||||||||||
- Definition Amount of expense recognized related to an embedded derivative, embedded in a subscription or financing subscription contract, excluding gains or losses resulting from fair value changes and other required remeasurements. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|